Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1995;86:621-633
© 1995 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbour, L.
Right arrow Articles by Pickard, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbour, L.
Right arrow Articles by Pickard, J

Articles

Controversies in thromboembolic disease during pregnancy: a critical review

LA Barbour and J Pickard

OBJECTIVE: To critically appraise the body of literature concerning strategies for the prevention of thromboembolism during pregnancy. DATA SOURCES: We used the Medline data base and reference lists of articles to identify all English-language papers examining thromboembolism during pregnancy. METHODS OF STUDY SELECTION: We identified 156 articles in the obstetric literature and 29 articles in the medical literature that referenced nonpregnant populations. Together, these articles form the primary data base on which most recommendations are based. DATA EXTRACTION AND SYNTHESIS: There are no level 1 trials (large randomized trials with definitive results) in the obstetric literature examining the efficacy of thromboembolism prophylaxis during pregnancy. There are only two level 2 trials (small randomized trials with uncertain results because of moderate to high alpha or beta error) that address prophylactic strategies in pregnant women with histories of thromboembolism or the antiphospholipid antibody syndrome. The remainder of the published trials are observational, some prospective but predominantly retrospective. Many of the recommendations from consensus panels regarding prophylactic strategies in pregnancy were based on level 1 trials in nonpregnant populations. CONCLUSION: Although women with a history of thromboembolic disease are at appreciable risk of recurrence during pregnancy, the exact incidence is unknown and there are no adequate efficacy trials demonstrating that prophylactic regimens are effective. Heparin is the anticoagulant of choice in pregnancy; however, changes in metabolism and clearance make adequate dosing problematic. Expert consensus panels disagree over the optimal management of pregnant women at risk for thromboembolism. Randomized controlled trials during pregnancy are needed if any progress is to be made in combating this lethal disorder.


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
G R IBALL, E V KENNEDY, and D S BRETTLE
Modelling the effect of lead and other materials for shielding of the fetus in CT pulmonary angiography
Br. J. Radiol., June 1, 2008; 81(966): 499 - 503.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
H. Casele and W. A. Grobman
Cost-effectiveness of Thromboprophylaxis With Intermittent Pneumatic Compression at Cesarean Delivery.
Obstet. Gynecol., September 1, 2006; 108(3): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. K. Yousefzadeh, M. B. Ward, and C. Reft
Internal Barium Shielding to Minimize Fetal Irradiation in Spiral Chest CT: A Phantom Simulation Experiment.
Radiology, June 1, 2006; 239(3): 751 - 758.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. V. Lee
Thromboembolism in Pregnancy: A Continuing Conundrum
Ann Intern Med, November 15, 2005; 143(10): 749 - 750.
[Full Text] [PDF]


Home page
Hum ReprodHome page
A.J. Carlin, R.G. Farquharson, S.M. Quenby, J. Topping, and W.D. Fraser
Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control
Hum. Reprod., May 1, 2004; 19(5): 1211 - 1214.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
U. Elkayam, H. Singh, A. Irani, and M. W. Akhter
Anticoagulation in Pregnant Women With Prosthetic Heart Valves
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 107 - 115.
[Abstract] [PDF]


Home page
RadiologyHome page
H. T. Winer-Muram, J. M. Boone, H. L. Brown, S. G. Jennings, W. C. Mabie, and G. T. Lombardo
Pulmonary Embolism in Pregnant Patients: Fetal Radiation Dose with Helical CT
Radiology, August 1, 2002; 224(2): 487 - 492.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B.M Weiss and O.M Hess
Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives
Eur. Heart J., January 2, 2000; 21(2): 104 - 115.
[PDF]


Home page
Obstet GynecolHome page
R. B. GHERMAN, T. M. GOODWIN, B. LEUNG, J. D. BYRNE, R. HETHUMUMI, and M. MONTORO
Incidence, Clinical Characteristics, and Timing of Objectively Diagnosed Venous Thromboembolism During Pregnancy
Obstet. Gynecol., November 1, 1999; 94(5): 730 - 734.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Pickard
Clinical Model for Management of Pulmonary Embolism
Ann Intern Med, September 21, 1999; 131(6): 474 - 474.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Obstetricians and Gynecologists.